Australia Markets closed

Why IDP Education, Medical Developments, & REA Group just hit record highs

James Mickleboro
success, high flyer, win, challenge

On Thursday the S&P/ASX 200 index broke through the 7,000 points mark for the first time in its history.

But it wasn’t just the benchmark index that was hitting a new high. Several ASX shares raced to new highs of their own yesterday. Here’s why they are on form:

IDP Education Ltd (ASX: IEL)

The IDP Education share price hit an all-time high of $20.08 on Thursday. This gain means the international student placement services company’s shares have now risen 77% since this time last year. The catalyst for this gain was the company’s strong performance in FY 2019 and its positive outlook. In FY 2019 IDP Education delivered total revenue of $598 million and EBITDA of $115 million. This represented an increase of 23% and 29%, respectively, on the prior corresponding period. Strong demand for language testing and placement services drove its impressive growth.

Medical Developments International Ltd (ASX: MVP)

The Medical Developments International share price hit an all-time high of $9.50 yesterday. The healthcare company’s shares have been on fire over the last 12 months due to a series of positive developments relating to its Penthrox product. Penthrox, better known as the green whistle, is an analgesic used by medical practitioners, the defence forces, paramedics, sports clubs, and surf lifesavers. The company has successfully expanded its use internationally over the last couple of years and has its eyes on two more major markets – the United States and China. Potential launches in these markets may not be far away, pending regulatory clearance.

REA Group Limited (ASX: REA)

The REA Group share price stormed to a record high of $114.75 on Thursday. Investors have been fighting to get hold of the property listings company’s shares due to the improving housing market. Property prices have been rising strongly in recent months, which should bring more homes onto the market and support increasing demand for listings. Combined with price increases and new revenue streams, this is expected to lead to solid profit growth from the second half of FY 2020 onwards.

The post Why IDP Education, Medical Developments, & REA Group just hit record highs appeared first on Motley Fool Australia.

If you missed out on these gains, don't worry. Because it isn't too late to snap up these ASX shares which have been tipped as strong buys.

NEW. Five Cheap and Good Stocks to Buy for 2020 and beyond!….

Our Motley Fool experts have just released a fantastic report, detailing 5 dirt cheap shares that you can buy in 2020.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield...

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.


More reading

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Medical Developments International Limited. The Motley Fool Australia has recommended REA Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2020